Search Results 641-650 of 8124 for zerona

  1. A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome - Mayo Clinic

    This is an international, multicenter, open-label, long-term safety study of ZX008 in pediatric and young adult subjects with Dravet syndrome who have ...

  2. A Study of Unesbulin Combined with Dacarbazine to Treat Advanced Leiomyosarcoma (LMS) - Mayo Clinic

    About this study. The primary purpose of this study is to determine the maximum tolerated dose (MTD) and overall safety profile of PTC596 in combination ...

  3. Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care - Mayo Clinic

    About this study. C3FIT's overall goal is to assess if patient outcomes are improved when the Comprehensive and Primary Stroke Center (CSC/PSC) system is ...

  4. Mayo Clinic

    Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.

  5. A Study of the Safety and Effectiveness of NP001 for Patients with Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of NP001 for treating patients who have amyotrophic lateral sclerosis (ALS) and evidence ...

  6. A Study to Investigate the Safety and Effectiveness of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Old - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial - Mayo Clinic

    A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute ...

  8. Mayo Clinic Biobank - Publications

    The Mayo Clinic Biobank provides important data and biospecimen resources to internationally recognized scientists whose work is published in leading scientific ...

  9. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis - Mayo Clinic

    The primary hypothesis of the study is that treatment with pacritinib results in a greater proportion of patients achieving ≥ 35% reduction in spleen volume ...

  10. Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) - Mayo Clinic

    intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...